MSB - Mesoblast Limited
ASX
->
Healthcare
->
Biotechnology
Melbourne,
Australia
Type: Equity
MSB price evolution
MSB
| (in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $62.96 | $62.96 | ||
| Short term investments | ||||
| Net receivables | $4.55 | $4.32 | $3.39 | $2.41 |
| Inventory | ||||
| Total current assets | $100.67 | $26.25 | $25.13 | $26.69 |
| Long term investments | $1.01 | $1.01 | ||
| Property, plant & equipment | $3.84 | $3.84 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $100.67 | $26.25 | $25.13 | $26.69 |
| Current liabilities | ||||
| Accounts payable | $7.07 | $7.07 | ||
| Deferred revenue | ||||
| Short long term debt | $16.49 | $16.49 | ||
| Total current liabilities | $5.34 | $4.13 | $4.48 | $5.72 |
| Long term debt | $102.44 | $102.44 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $5.34 | $4.13 | $4.48 | $5.72 |
| Shareholders' equity | ||||
| Retained earnings | $95.33 | $22.12 | $20.65 | $20.98 |
| Other shareholder equity | $78.3 | $78.3 | ||
| Total shareholder equity | $480.36 | $480.36 | ||
| (in millions $) | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $62.96 | $71.32 | $60.45 | $136.38 |
| Short term investments | ||||
| Net receivables | $20.48 | $6.53 | $4.4 | $4.84 |
| Inventory | ||||
| Total current assets | $86.46 | $81.66 | $69.84 | $148.23 |
| Long term investments | $1.01 | $1.76 | $1.76 | $2.08 |
| Property, plant & equipment | $3.84 | $6.49 | $9.96 | $12.14 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $669.15 | $669.42 | $662.14 | $744.72 |
| Current liabilities | ||||
| Accounts payable | $7.07 | $20.14 | $23.08 | $19.6 |
| Deferred revenue | ||||
| Short long term debt | $16.49 | $10.01 | $8.2 | $55.97 |
| Total current liabilities | $73.24 | $41.98 | $51.37 | $94.27 |
| Long term debt | $102.44 | $106.48 | $98.7 | $49.53 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $188.8 | $167.58 | $165.1 | $163.32 |
| Shareholders' equity | ||||
| Retained earnings | -$908.76 | -$820.8 | -$738.92 | -$541.75 |
| Other shareholder equity | $78.3 | $73.52 | $70.65 | -$39.79 |
| Total shareholder equity | $480.36 | $501.84 | $497.04 | $581.4 |
| (in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $79 | $6.49 | $6.25 | $6.23 |
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $0.68 | $1.09 | $2.77 | $1.54 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | $78.33 | $5.4 | $3.48 | $4.69 |
| Income (for common shares) | ||||
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7.5 | $10.21 | $7.46 | $32.16 |
| Cost of revenue | $54.92 | $63.57 | $32.72 | $25.31 |
| Gross Profit | -$47.42 | -$53.36 | -$25.26 | $6.85 |
| Operating activities | ||||
| Research & development | $27.19 | $32.82 | $51.54 | $54.73 |
| Selling, general & administrative | $25.37 | $27.21 | $30.87 | $25.61 |
| Total operating expenses | $76.79 | $90.78 | $92.62 | $105.04 |
| Operating income | -$69.29 | -$80.57 | -$85.16 | -$72.89 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.21 | -$0.24 | -$0.82 | -$9.41 |
| Interest expense | -$19.44 | -$16.91 | ||
| Net income | ||||
| Net income | -$81.89 | -$91.35 | -$98.81 | -$77.94 |
| Income (for common shares) | -$81.89 | -$91.35 | -$98.81 | -$77.94 |
| (in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | -$12.6 | -$8.66 | -$4.85 | -$4.59 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$12.6 | -$8.66 | -$4.85 | -$4.59 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $71.93 | -$2.35 | -$2.35 | $10.01 |
| (in millions $) | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 3 Mar 2022 |
|---|---|---|---|---|
| Net income | -$87.96 | -$81.89 | -$91.35 | |
| Operating activities | ||||
| Depreciation | $3.18 | $2.61 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$48.46 | -$63.27 | -$65.78 | |
| Investing activities | ||||
| Capital expenditures | -$0.27 | -$0.26 | -$0.16 | |
| Investments | ||||
| Total cash flows from investing | -$0.1 | -$0.19 | -$0.23 | $9.91 |
| Financing activities | ||||
| Dividends paid | -$37.52 | |||
| Sale and purchase of stock | $65.41 | $88.64 | $0.21 | |
| Net borrowings | -$13.52 | -$2.66 | -$6.33 | |
| Total cash flows from financing | $40.25 | $74.5 | -$9.87 | -$37.52 |
| Effect of exchange rate | -$0.08 | -$0.16 | ||
| Change in cash and equivalents | -$8.36 | $10.87 | -$76.43 | $35.23 |
News
Fundamentals
| Market cap | $22.20M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 13.12M |
| Revenue | $97.97M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $91.90M |
| Revenue Q/Q | 1.51K% |
| Revenue Y/Y | 301.91% |
| P/E ratio | 0.24 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.23 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $7.00 |
|---|---|
| ROA | 205.66% |
| ROE | N/A |
| Debt/Equity | 0.39 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 18.84 |
| Quick ratio | N/A |